High Incidence of BK-Virus-Related Hemorrhagic Cystitis after Busulfan/Fludarabine Myeloablative Conditioning in Allogeneic Stem Cell Transplantation Recipients

MLA

Gorgun Akpek, et al. “High Incidence of BK-Virus-Related Hemorrhagic Cystitis after Busulfan/Fludarabine Myeloablative Conditioning in Allogeneic Stem Cell Transplantation Recipients.” Blood, vol. 108, Nov. 2006, p. 5254. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c92469d82edc0e166ed637ff24e46641&authtype=sso&custid=ns315887.

APA

Gorgun Akpek, Kristen Barton, Barry Meisenberg, Kathleen Ruehle, Aaron P. Rapoport, Ashraf Badros, & Saul Yanovich. (2006). High Incidence of BK-Virus-Related Hemorrhagic Cystitis after Busulfan/Fludarabine Myeloablative Conditioning in Allogeneic Stem Cell Transplantation Recipients. Blood, 108, 5254.

Chicago

Gorgun Akpek, Kristen Barton, Barry Meisenberg, Kathleen Ruehle, Aaron P. Rapoport, Ashraf Badros, and Saul Yanovich. 2006. “High Incidence of BK-Virus-Related Hemorrhagic Cystitis after Busulfan/Fludarabine Myeloablative Conditioning in Allogeneic Stem Cell Transplantation Recipients.” Blood 108 (November): 5254. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........c92469d82edc0e166ed637ff24e46641&authtype=sso&custid=ns315887.